FAP and neoplasm: On the contrary, the expression of FAP, a molecule involved in epithelial-to-mesenchymal transition and tumor invasion [70], was unvarying after both EV-CTR and EV-ASA treatment, showing the activation or reduction of a selective pathway mediated by tumor-derived EV.